Thank you for sharing!

Your article was successfully shared with the contacts you provided.
Martin Shkreli (left), former Chief Executive Officer of Turing Pharmaceuticals, leaving the hearing room after appearing before the House Committee on Oversight and Government Reform during a hearing titled "Developments in the Prescription Drug Market," on February 4, 2016. Mr. Shkreli, on the advice of his attorney, Ben Brafman, right, of Brafman & Associates, refused to answer any questions. Photo by Diego M. Radzinschi/THE NATIONAL LAW JOURNAL. Martin Shkreli (left)) and his attorney Ben Brafman. (Photo: Diego M. Radzinschi/ALM)

If former pharmaceutical executive Martin Shkreli seeks to cure COVID-19, he can do so from prison, prosecutors argued Tuesday in their response to Shkreli’s motion for release in the Eastern District of New York.

Shkreli, who was sentenced to seven years in prison for securities fraud in March 2018, filed for release from his low-security facility in Allenwood, Pennsylvania, on April 22. His lawyer Benjamin Brafman argued that Shkreli is a skilled medical researcher already devoted to studying a drug that could “bring relief and treatment to people suffering from COVID-19.”

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Advance® Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]

Jane Wester

Jane Wester is a litigation reporter for the New York Law Journal. Email her at [email protected] or find her on Twitter @janewester.

More from this author

Reprints & Licensing
Mentioned in a Law.com story?

License our industry-leading legal content to extend your thought leadership and build your brand.


ALM Legal Publication Newsletters

Sign Up Today and Never Miss Another Story.

As part of your digital membership, you can sign up for an unlimited number of a wide range of complimentary newsletters. Visit your My Account page to make your selections. Get the timely legal news and critical analysis you cannot afford to miss. Tailored just for you. In your inbox. Every day.

Copyright © 2021 ALM Media Properties, LLC. All Rights Reserved.